NASDAQ: NEPH - Nephros, Inc.

Yield per half year: +31.6%
Dividend yield: 0.00%
Sector: Healthcare

Nephros, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 64.63 -100% -11.88 -100%
P/S 2.25 33.51 -93.27%
P/BV 3.84 4.52 -15.02%
P/FCF 0 34.27 -100%
Ev/Ebitda -21.48 -19.11 12.38%
Ev/S 2.08 22.47 -90.74%
Ev/FCF 39.39 39.86 -1.19%
E/P 0 0.0134 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-9.69 -14.94 -35.19% -29.94 -67.65%
ROE -18.84 6.54 -388.22%
ROA -13.28 -0.7601 1646.97%
ROIC 0 7.63 -100%
ROS -11.06 -28.35 -60.98%
ROCE -19.06 12.21 -256.07%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.33 -3.85 -65.43% -0.8932 +49.07%
Nеt Debt/Ebitda 1.79 -2.93 -161.11%
Debt/Ratio 0.1548 0.17 -8.95%
Debt/Equity 0.4191 0.6659 -37.06%
Debt/Net Income -1.17 0.8956 -230.16%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5431 -100% 0 0%
Number of years of dividend growth 0 0.9211 -100%
DSI 0 0.2368 -100%
Average dividend growth 0 1.24 -100%
Average percentage for 5 years 0 0.4869 -100%
Average percentage for payments 0 64.77 -100%
Difference from average difference in sector -0.5431

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
5/10
38.23 100.43 -61.93%
Growth impulse Ebitda in 5 years -57.53 49.27 -216.76%
Growth impulse Net Income in 5 years -50.78 -8.2 519.27%
Growth impulse FCF in 5 years -132.7 52.45 -353%
Growth impulse EPS in 5 years -64.02 5.84 -1196.23%
IP Score
2.78/10

Similar companies

Illumina

Incyte

ImmunoGen

DENTSPLY SIRONA

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription